1.Research progress on PD-1/PD-L1 inhibitors in prostate cancer immunotherapy
Chinese Journal of Clinical Oncology 2017;44(16):831-834
The annual incidence of prostate cancer (PCa) continually increases. New PCa immune therapy has become the fourth line antitumor treatment following surgery, radiotherapy and chemotherapy. As the most promising research direction in cancer immunotherapy,immune checkpoint inhibitors, such as programmed cell death-1 and programmed cell death-ligand 1 (PD-1/PD-L1) inhibitors, block PD-1 and its ligand PD-L1 and then terminate the negative control signal to the T cell, thereby facilitating T cell recovery and reversal of tumor immune-escaping mechanism. These processes restore the capability of T cells for immune response and inhibit and kill tumor cells. This review summarizes the progress on the current application of PD-1/PD-L1 inhibitors in PCa clinical trials.
2.THYROGLOBULIN ANTIBODY PRODUCTION BY CULTURED PERIPHERAL BLOOD MONONUCLEAR CELLS FROM PATIENTS WITH AUTOIMMUNE THYROID DISEASE
Chinese Journal of Endocrinology and Metabolism 1985;0(02):-
Thyroglobulin antibody (TGA) production in vitro by cultured peripheral blood mononuclear cells (PBMC) from patients with autoimmune thyroid disease (AITD) was measured by ELISA technique. PBMC from patients with AITD could synthesize and secret detectable amount of TGA. The average positive rate of TGA production in vitro was 31.25%. PBMC from the patients with Hashimoto thyroiditis (HT) could produce TGA more easily than that from the patients with Graves'disease (GD). The average positive rate was 44.19% in HT and 16.22% in GD. Pokeweed mitogen could increase TGA production, but soluable thyroglobulin could not stimulate TGA synthesis and secretion. Antithyroid drug methi-mazole had some inhibition effect on TGA production in vitro. A significant positive correlation between the serum TGA and the amount of TGA produced in vitro by PBMC from HT patients (r = 0.4, P
3.THE EFFECT OF CHRONIC LITHIUM. ON CALMODULIN ACTIVITY IN RAT BRAIN
Journal of Chongqing Medical University 1986;0(04):-
Lithium(Li) salt is. a kind of effective drug commonly used in the treatment and prevention of mental disorders, but its active mechanism is still not well understood. Getting on for twenty years, many research have been reported on relationship between Li salt and second messenger system, especially the effect of Li salt on adenylate cyclase. Identical result is not obtained and there are few reports on brain calmodulin (CaM) activity change by Li salt. The aim of present expcri- ment is to determine the content of CaM in raet brain by phosphodiesterase (PED) method after chronic application of Li salt and discuss preliminary the molecular mechanism of Li salt action. The result showed that marked change has happened in the content of CaM in rat brain after chronic application of Li salt. It is ins-plied that Li salt brings its action into play probably by changing the content of CaM in rat brain
6.Mutual promotion, mutual assistance and mutual inhibition in the compatibility of acupoints.
Chinese Acupuncture & Moxibustion 2015;35(10):1021-1024
Mutual promotion, mutual assistance and mutual inhibition are commonly for the compatibility of Chinese herbs, but they are also existed among the acupoints. In the paper, the relevant literature on acupoint, compatibility was collected and the mutual promotion, mutual assistance and mutual inhibition relationships of acupoints were described. The laws of the above mentioned combinations, the theoretic evidences and modern researches were summarized briefly. The mutual promotion and mutual assistance refer to the coordination of acupoints, presenting the relationship of the primary and the secondary about the mutual assistance. Hereby, the acupoints could be divided into the simple assistant acupoints and the acupoints from the affected meridians. The mutual inhibition is used to describe the antagonism effect in acupoint combination. There are more researches on the mutual promotion of acupoint combination but less ones on the mutual inhibition and its mechanism is just hypothetic. It is very important to have the deep study on those compatibility relationships for the improvement of acupuncture efficacy and to elaborate the effect mechanism.
Acupuncture Points
;
Acupuncture Therapy
;
history
;
China
;
History, Ancient
;
Humans
;
Medicine in Literature
;
Meridians
9.Evaluation and treatment of hydronephrosis in fetus and neonate
Chinese Journal of Applied Clinical Pediatrics 2017;32(11):811-815
Congenital hydronephrosis is the main cause of childhood chronic renal disease and renal failure,which is also one of the most common anomalies in pediatric urology division.Although the operation is performed to treat obstruction,the renal function of patients get worse and worse,postoperatively.Up to date,there are lots of controversies in evaluation of hydronephrosis and treatment at prenatal and postnatal.According to recent articles,the recent examinations,evaluation system,follow-up and treatment strategies of hydronephrosis are introduced.
10.Improvement of Sitagliptin on Islet B-cell Function in Patients with Type 2 Diabetes:A Meta-analysis
China Pharmacy 2017;28(15):2073-2076
OBJECTIVE:To evaluate the improvement effects of sitagliptin on islet B-cell function in type 2 diabetic patients systematically,and to provide evidenced-based reference. METHODS:Retrieved from PubMed,Cochrane library,EMBase, CJFD,Wanfang database,VIP and CBM,RCTs about sitagliptin alone or combined with routine plan(trial group)vs. placbo alone or combined with routine plan(control group)in the treatment of type 2 diabetes were collected. Two reviewers independent-ly screened studies according to exclusion and inclusion criteria,extracted data,and assessed the methodological quality according to Cochrane Manual 5.1.0. Meta-analysis was performed by using RevMan 5.3 software. RESULTS:A total of 5 RCTs were includ-ed,involving 1253 patients. The result of Meta-analysis showed that changes of islet B cell function index(Homa-B)[sitagliptin alone group:MD=9.21,95%CI(4.16,14.25),P<0.001;drug combination group:MD=7.24,95%CI(0.80,13.68),P=0.03] and changes of insulin resistance index(Homa-IR)[sitagliptin alone group:MD=-0.40,95%CI(-0.44,-0.36),P<0.001;drug combination group:MD=-0.35,95%CI(-0.63,-0.07),P=0.02] of trial group were significantly better than those of control group,with statistical significance. CONCLUSIONS:Sitagliptin shows certain therapeutic efficacy in improving islet B cell func-tion and insulin resistance.